Tessera Therapeutics Revenue and Competitors

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • Tessera Therapeutics's estimated annual revenue is currently $70.4M per year.(i)
  • Tessera Therapeutics's estimated revenue per employee is $155,000
  • Tessera Therapeutics's total funding is $431.8M.
  • Tessera Therapeutics's current valuation is $1.7B. (April 2022)

Employee Data

  • Tessera Therapeutics has 454 Employees.(i)
  • Tessera Therapeutics grew their employee count by 24% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Our mission is to cure disease by writing the code of life



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Tessera Therapeutics News

2022-04-17 - Tessera Therapeutics Raises Over $300M in Series C Financing

Tessera Therapeutics, a Somerville, MA-based biotechnology company, raised over $300M in Series C funding.

2022-04-17 - Tessera Therapeutics stacks up more than $300M in series C funds ...

Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million...

2022-04-17 - Tessera Therapeutics Announces Over $300M Series C Financing ...

Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding